Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | SELL | P14151 | 1/20 | 0.41 |
| ▸ | SELP | P16109 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.38 |
| ▸ | TPMT | P51580 | 4/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.37 |
| ▸ | DNMT3B | Q9UBC3 | 1/20 | 0.37 |
| ▸ | DNMT3L | Q9UJW3 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3369498 | 0.88 | TDP1 (0.50) | TDP1MAPTSELLSELPHTT | |
| SCHEMBL4216080 | 0.86 | TDP1 (0.49) | TDP1MAPTSELLSELPHTT | |
| Hydrochloric Acid SCHEMBL6437034 | 0.86 | TDP1 (0.47) | TDP1MAPTHTTPOLBHSD17B10 | |
| SCHEMBL25232693 | 0.85 | TDP1 (0.47) | TDP1MAPTSELLSELPHTT | |
| SCHEMBL3365334 | 0.85 | TDP1 (0.47) | TDP1MAPTSELLSELPHTT | |
| SCHEMBL3370741 | 0.85 | TDP1 (0.47) | TDP1MAPTSELLSELPHTT | |
| SCHEMBL1940681 | 0.85 | HMGCR (0.47) | TDP1MAPTHTTDRD2POLB | |
| SCHEMBL28665839 | 0.84 | PPARA (0.46) | TDP1MAPTPPARGPPARAGABRP | |
| SCHEMBL11895245 | 0.83 | TDP1 (0.46) | TDP1MAPTSELLSELPHTT | |
| Hydrochloric Acid SCHEMBL7999971 | 0.83 | NNMT (0.38) | TDP1MAPTHTTDRD2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 403 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118678895-A | Article for an aerosol delivery system and method of manufacturing an article for an aerosol delivery system | 尼科创业贸易有限公司 | 2024-09-20 | — | — | CN | claimed |
| CN-118401125-A | Assembly for use in or as an article of an aerosol provision system | 尼科创业贸易有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-118265464-A | Aerosol generating material | 尼科投资贸易有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-118159148-A | Aerosol-generating composition comprising nicotine and an acid or nicotine salt | 莱战略控股公司 | 2024-06-07 | — | — | CN | claimed |
| CN-117813019-A | Assembly for an article for use in an aerosol provision system | 尼科创业贸易有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117750893-A | Assembly for an article for use in an aerosol provision system | 尼科创业贸易有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-117561005-A | Assembly for an article for use in an aerosol provision system | 尼科创业贸易有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-117098469-A | Assembly for an article for use in an aerosol provision system | 尼科创业贸易有限公司 | 2023-11-21 | — | — | CN | claimed |
| CN-113897244-B | Preparation method and application of cigarette spice | 深圳市兰科植物保护研究中心 | 2023-10-27 | — | — | CN | claimed |
| CN-113811198-B | Aerosol supply system | 尼科创业贸易有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-113795153-A | Methods and compositions for improving the taste of sugarless cola soda water and other beverages | 格雷戈里·阿哈罗尼安 | 2021-12-14 | — | — | CN | claimed |
| CN-122094577-A | Component for aerosol supply article | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122094581-A | Compatibility of consumables with aerosol provision devices | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122074723-A | Method of manufacturing an aerosol generator | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122070060-A | Article for or as an aerosol supply system | 尼科创业贸易有限公司 | 2026-05-19 | — | — | CN | disclosed |
| WO-2004050080-A1 | TREATMENT OF INFLAMMATORY DISORDERS WITH 2,3-BENZODIAZEPINES | VELA PHARMACEUTICALS, INC. (US) | 2004-06-17 | — | — | WO | disclosed |
| WO-2004050616-A2 | TREATMENT OF IRRITABLE BOWEL SYNDROME AND NONULCER DYSPEPSIA WITH SUBSTITUTED 2,3-BENZODIAZEPINES | VELA PHARMACEUTICALS, INC. (US) | 2004-06-17 | — | — | WO | disclosed |
| US-20040106602-A1 | Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines | VELA ACQUISITION CORPORATION | 2004-06-03 | — | — | US | disclosed |
| US-20040106601-A1 | Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines | VELA ACQUISITION CORPORATION | 2004-06-03 | — | — | US | disclosed |
| US-6638928-B1 | Benzodiazepines administered for irritable bowel syndrome and nonulcer dyspepsia. | VELA PHARMACEUTICALS, INC. | 2003-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106602-A1 | Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines | LTB4R2, LTB4R, PTGER4 | TDP1 4276/4885MAPT 2791/4885SELL 718/4885 |
| US-20040106601-A1 | Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines | OPRL1, OPRD1, GABRR1 | TDP1 4352/4885MAPT 4329/4885SELL 690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.